Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma

Immunomonitoring of Interventional Radiology Procedures in the Management of Hepatocellular Carcinoma

This cohort study compares immune response induced in two groups of small HCC patients treated by ablation (group1 RFA, group 2 MWA). Patients will benefit for tumoral and non tumoral biopsies prior to treatment and stepped peripheral blood samples juste before ablation and during the first month after.

Inclusion Criteria:

• Histologically proven HCC for less than 3 months before ablation
• Decision of ablation treatment in multidisciplinary meeting

Exclusion Criteria:

• Fibrolamellar HCC
• Hepatocholangiocarcinoma